Risperidone 0.25 MG Oral Tablet — RxCUI 312828
RxNorm drug concept · Semantic clinical drug
RxCUI 312828
Semantic clinical drug · SCD
● Current RxNorm concept 90 FDA products
211 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI312828
Official nameRisperidone 0.25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped90
Package NDCs mapped211
Reported Medicaid activity (SDUD)3,048,669 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Risperidone Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- The injectable form gives you a steady, consistent level of medication over weeks — so you don't have to remember a daily pill. This can make a big difference in keeping symptoms u...
- Why is my doctor using an injection instead of a pill?
- It depends on the specific product your doctor prescribes. With some formulations, your doctor will have you take oral risperidone for about three weeks after your first injection...
- Will I need to take anything by mouth when I first start the injection?
🕸️ Concept Web — How Risperidone 0.25 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Risperidone 0.25 MG Oral Tablet
RxCUI 312828 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Risperidone
35636IN
-
Risperidone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Risperdal
152318BN
-
Risperdal
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Risperidone Oral Tablet
373791SCDF -
Risperidone Oral Product
1165480SCDG -
Risperidone Pill
1165481SCDG -
Risperidone Oral Tablet [Risperdal]
368231SBDF -
Risperdal Oral Product
1185341SBDG -
Risperdal Pill
1185342SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Risperidone Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Risperidone 0.25 MG
331477SCDC -
Risperidone 0.25 MG Oral Tablet [Risperdal]
262077SBD -
Risperidone 0.25 MG [Risperdal]
574662SBDC
-
Risperidone 0.25 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Risperidone 0.25 MG
SCDC · 331477 -
Risperidone Oral Tablet
SCDF · 373791 -
Risperidone Oral Product
SCDG · 1165480 -
Risperidone Pill
SCDG · 1165481
Brand-Name Concepts
-
Risperidone 0.25 MG Oral Tablet [Risperdal]
SBD · 262077 -
Risperidone 0.25 MG [Risperdal]
SBDC · 574662 -
Risperidone Oral Tablet [Risperdal]
SBDF · 368231 -
Risperdal Oral Product
SBDG · 1185341 -
Risperdal Pill
SBDG · 1185342 -
Risperdal
BN · 152318
📦 FDA Products & Package NDCs
90 products · 211 package NDCs
211 package NDCs map to RxCUI 312828 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 27241-0005-50 | 500 TABLET in 1 BOTTLE (27241-005-50) | RISPERIDONE | Ajanta Pharma USA Inc. | 2014-03-28 |
| 27241-0006-06 | 60 TABLET in 1 BOTTLE (27241-006-06) | RISPERIDONE | Ajanta Pharma USA Inc. | 2014-03-28 |
| 27241-0006-50 | 500 TABLET in 1 BOTTLE (27241-006-50) | RISPERIDONE | Ajanta Pharma USA Inc. | 2014-03-28 |
| 42291-0908-50 | 500 TABLET in 1 BOTTLE (42291-908-50) | Risperidone | AvKARE | 2021-09-10 |
| 42291-0909-50 | 500 TABLET in 1 BOTTLE (42291-909-50) | Risperidone | AvKARE | 2021-09-10 |
| 42291-0910-50 | 500 TABLET in 1 BOTTLE (42291-910-50) | Risperidone | AvKARE | 2021-09-10 |
| 42291-0911-50 | 500 TABLET in 1 BOTTLE (42291-911-50) | Risperidone | AvKARE | 2021-09-10 |
| 42291-0912-50 | 500 TABLET in 1 BOTTLE (42291-912-50) | Risperidone | AvKARE | 2021-09-10 |
| 42291-0974-50 | 500 TABLET, FILM COATED in 1 BOTTLE (42291-974-50) | Risperidone | AvKARE | 2025-03-06 |
| 42291-0974-60 | 60 TABLET, FILM COATED in 1 BOTTLE (42291-974-60) | Risperidone | AvKARE | 2025-03-06 |
| 42291-0975-50 | 500 TABLET, FILM COATED in 1 BOTTLE (42291-975-50) | Risperidone | AvKARE | 2025-03-06 |
| 42291-0975-60 | 60 TABLET, FILM COATED in 1 BOTTLE (42291-975-60) | Risperidone | AvKARE | 2025-03-06 |
| 42291-0976-50 | 500 TABLET, FILM COATED in 1 BOTTLE (42291-976-50) | Risperidone | AvKARE | 2025-03-06 |
| 42291-0976-60 | 60 TABLET, FILM COATED in 1 BOTTLE (42291-976-60) | Risperidone | AvKARE | 2025-03-06 |
| 43547-0339-06 | 60 TABLET in 1 BOTTLE (43547-339-06) | Risperidone | Solco Healthcare US, LLC | 2014-06-01 |
| 43547-0339-50 | 500 TABLET in 1 BOTTLE (43547-339-50) | Risperidone | Solco Healthcare US, LLC | 2014-06-01 |
| 43547-0340-06 | 60 TABLET in 1 BOTTLE (43547-340-06) | Risperidone | Solco Healthcare US, LLC | 2014-06-01 |
| 43547-0340-50 | 500 TABLET in 1 BOTTLE (43547-340-50) | Risperidone | Solco Healthcare US, LLC | 2014-06-01 |
| 43547-0341-06 | 60 TABLET in 1 BOTTLE (43547-341-06) | Risperidone | Solco Healthcare US, LLC | 2014-06-01 |
| 43547-0341-50 | 500 TABLET in 1 BOTTLE (43547-341-50) | Risperidone | Solco Healthcare US, LLC | 2014-06-01 |
| 43547-0342-06 | 60 TABLET in 1 BOTTLE (43547-342-06) | Risperidone | Solco Healthcare US, LLC | 2014-06-01 |
| 43547-0342-50 | 500 TABLET in 1 BOTTLE (43547-342-50) | Risperidone | Solco Healthcare US, LLC | 2014-06-01 |
| 43547-0343-06 | 60 TABLET in 1 BOTTLE (43547-343-06) | Risperidone | Solco Healthcare US, LLC | 2014-06-01 |
| 43547-0343-50 | 500 TABLET in 1 BOTTLE (43547-343-50) | Risperidone | Solco Healthcare US, LLC | 2014-06-01 |
| 43547-0344-06 | 60 TABLET in 1 BOTTLE (43547-344-06) | Risperidone | Solco Healthcare US, LLC | 2014-06-01 |
| 43547-0344-50 | 500 TABLET in 1 BOTTLE (43547-344-50) | Risperidone | Solco Healthcare US, LLC | 2014-06-01 |
| 50090-3340-00 | 30 TABLET in 1 BOTTLE (50090-3340-0) | RISPERIDONE | A-S Medication Solutions | 2018-01-22 |
| 59746-0221-05 | 500 TABLET in 1 BOTTLE (59746-221-05) | Risperidone | Jubilant Cadista Pharmacuticals Inc. | 2025-10-15 |
| 59746-0221-60 | 60 TABLET in 1 BOTTLE (59746-221-60) | Risperidone | Jubilant Cadista Pharmacuticals Inc. | 2025-10-15 |
| 59746-0222-05 | 500 TABLET in 1 BOTTLE (59746-222-05) | Risperidone | Jubilant Cadista Pharmacuticals Inc. | 2025-10-15 |
| 59746-0222-60 | 60 TABLET in 1 BOTTLE (59746-222-60) | Risperidone | Jubilant Cadista Pharmacuticals Inc. | 2025-10-15 |
| 59746-0223-05 | 500 TABLET in 1 BOTTLE (59746-223-05) | Risperidone | Jubilant Cadista Pharmacuticals Inc. | 2025-10-15 |
| 59746-0223-60 | 60 TABLET in 1 BOTTLE (59746-223-60) | Risperidone | Jubilant Cadista Pharmacuticals Inc. | 2025-10-15 |
| 59746-0224-05 | 500 TABLET in 1 BOTTLE (59746-224-05) | Risperidone | Jubilant Cadista Pharmacuticals Inc. | 2025-10-15 |
| 59746-0224-60 | 60 TABLET in 1 BOTTLE (59746-224-60) | Risperidone | Jubilant Cadista Pharmacuticals Inc. | 2025-10-15 |
| 59746-0225-05 | 500 TABLET in 1 BOTTLE (59746-225-05) | Risperidone | Jubilant Cadista Pharmacuticals Inc. | 2025-10-15 |
| 59746-0225-60 | 60 TABLET in 1 BOTTLE (59746-225-60) | Risperidone | Jubilant Cadista Pharmacuticals Inc. | 2025-10-15 |
| 59746-0226-05 | 500 TABLET in 1 BOTTLE (59746-226-05) | Risperidone | Jubilant Cadista Pharmacuticals Inc. | 2025-10-15 |
| 59746-0226-60 | 60 TABLET in 1 BOTTLE (59746-226-60) | Risperidone | Jubilant Cadista Pharmacuticals Inc. | 2025-10-15 |
| 62135-0600-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-600-60) | Risperidone | Chartwell RX, LLC | 2023-12-29 |
| 62135-0601-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-601-60) | Risperidone | Chartwell RX, LLC | 2023-12-29 |
| 62135-0602-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-602-60) | Risperidone | Chartwell RX, LLC | 2023-12-29 |
| 62135-0603-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-603-60) | Risperidone | Chartwell RX, LLC | 2023-12-29 |
| 62135-0604-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-604-60) | Risperidone | Chartwell RX, LLC | 2023-12-29 |
| 62135-0605-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-605-60) | Risperidone | Chartwell RX, LLC | 2023-12-29 |
| 63187-0418-60 | 60 TABLET, FILM COATED in 1 BOTTLE (63187-418-60) | risperidone | Proficient Rx LP | 2019-01-01 |
| 65841-0665-01 | 100 TABLET, FILM COATED in 1 BOTTLE (65841-665-01) | risperidone | Zydus Lifesciences Limited | 2008-11-13 |
| 65841-0665-05 | 500 TABLET, FILM COATED in 1 BOTTLE (65841-665-05) | risperidone | Zydus Lifesciences Limited | 2008-11-13 |
| 65841-0665-06 | 30 TABLET, FILM COATED in 1 BOTTLE (65841-665-06) | risperidone | Zydus Lifesciences Limited | 2008-11-13 |
| 65841-0665-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (65841-665-10) | risperidone | Zydus Lifesciences Limited | 2008-11-13 |
Observed labelers:
Zydus Lifesciences Limited (36) ·
Zydus Pharmaceuticals USA Inc. (36) ·
Torrent Pharmaceuticals Limited (27) ·
Ajanta Pharma USA Inc. (12) ·
Amneal Pharmaceuticals NY LLC (12) ·
Jubilant Cadista Pharmacuticals Inc. (12)
· +12 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.